54 citations · 78 across the 3 of their papers we have counts for
Showing stat.MEShow all
2 papers · 1 filter
stat.ME2020
Endpoints for randomized controlled clinical trials for COVID-19 treatments
Lori E Dodd, Dean Follmann, Jing Wang +12
Introduction: Endpoint choice for randomized controlled trials of treatments for COVID-19 is complex. A new disease brings many uncertainties, but trials must start rapidly. COVID-…
stat.ME2020
Efficient model-based Bioequivalence Testing
Kathrin Möllenhoff, Florence Loingeville, Julie Bertrand +8
The classical approach to analyze pharmacokinetic (PK) data in bioequivalence studies aiming to compare two different formulations is to perform noncompartmental analysis (NCA) fol…